The urgent hospitalization of the wife of a key witness prompted a federal judge to indefinitely postpone a bellwether trial in the multi-district litigation over C.R. Bard‘s (NYSE:BCR) recalled Avaulta pelvic mesh.
A federal jury in the re-trial of a bellwether personal injury lawsuit filed against C.R. Bard (NYSE:BCR) over its Avaulta pelvic mesh slapped the medical device company with a $2 million judgment yesterday.
Health care giant Johnson & Johnson (NYSE:JNJ) found itself again in the hot seat as new reports claim the company sold a transvaginal mesh product in the U.S. for 3 years before obtaining appropriate FDA clearance.